title: [New developments in hormone replacement therapy].
abstract: Hormone replacement therapy with estrogen and progesterone does not appear to protect against Alzheimer's disease and does not improve cognitive functioning. Long-term administration of estrogen as monotherapy may be associated with an increased risk of ovarian cancer.
authors.affiliation: Universitätsklinik Graz. Geburtshilflich-gynäkologische Universitätsklinik, Auenbruggerplatz 14, AT-8036 Graz (Osterreich). @kfunigraz.ac.at
authors.forename: R
authors.initials: R
authors.lastname: Winter
authors.forename: U
authors.initials: U
authors.lastname: Haller
authors.forename: H
authors.initials: H
authors.lastname: Hepp
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000453:epidemiology; D001943:Breast Neoplasms / Q000453:epidemiology; D016022:Case-Control Studies; D003071:Cognition / Q000187:drug effects; D015331:Cohort Studies; D004311:Double-Blind Method; D016889:Endometrial Neoplasms / Q000453:epidemiology; D015914:Estrogen Replacement Therapy / Q000009:adverse effects / Q000639:trends*; D004967:Estrogens / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D008593:Menopause; D015201:Meta-Analysis as Topic; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000453:epidemiology; D010919:Placebos; D017698:Postmenopause; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D012189:Retrospective Studies; D012306:Risk; D012307:Risk Factors; D013997:Time Factors
chemical_list: D004967:Estrogens; D010919:Placebos